Suhagra 25 Mg – What Is Suhagra 25 Mg? How Does It Work?, Side Effects, Dosage And More
Suhagra 25 mg is an oral medication that treats erectile dysfunction (ED). It contains sildenafil citrate which relaxes blood vessels in the penis and allows for increased blood flow during sexual stimulation.
This tablet is very effective and powerful for treating Erectile dysfunction . suhagra is manufacture by one of leading in India that is cipla pvt ltd .
What Is Suhagra?
Suhagra 25 mg is a prescription medicine used to treat ED. It belongs to a group of medicines called phosphodiesterase type 5 inhibitors (PDE5i) and works by relaxing muscles in the penis so that it becomes easier to achieve and maintain an erection.
Suhagra 25 mg Uses :
This drug does not protect users against sexually transmitted diseases ( HIV, hepatitis B, gonorrhea, syphilis). Do not consume more than once daily. A high-calorie diet may delay the effect of the drug. The other condition that the medication is used for is pulmonary arterial hypertension.
What are the Side effects of Suhagra 25 Mg?
- Trouble sleeping
- Bloody and cloudy urine
- Visual disturbances
- Sensitivity to light
- Prolonged and painful erection
- Painful urination
- Excessive tearing of the eye
- Ringing or buzzing in the ears
What are the benefits of Suhagra 25 Mg?
Erectile dysfunction or barrenness is a condition where a man can’t accomplish/keep an erection firm enough for sex. This might be because of actual issues like physical issues, infections like benign prostatic hypertrophy, diabetes, neuropathy, prostate disease, and mental causes like uneasiness, stress, melancholy, and so forth. Propensities like smoking, drinking, & so on could likewise add to ED (Erectile Dysfunction).
Suhagra 25Mg Tablet supports an erection by expanding the bloodstream to the penis. While treating the fundamental reason for ED is critical, it is also essential to go through guiding and way of life changes alongside treatment with this medication to accomplish the ideal impact.
There are no reviews yet.